BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18551075)

  • 21. OX40 controls functionally different T cell subsets and their resistance to depletion therapy.
    Kroemer A; Xiao X; Vu MD; Gao W; Minamimura K; Chen M; Maki T; Li XC
    J Immunol; 2007 Oct; 179(8):5584-91. PubMed ID: 17911646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective depletion of alloreactive T cells leads to long-term islet allograft survival across a major histocompatibility complex mismatch in diabetic mice.
    Hu M; Wu J; Zhang GY; Wang YM; Watson D; Yi S; Hawthorne WJ; O'Connell PJ; Alexander SI
    Cell Transplant; 2013; 22(10):1929-41. PubMed ID: 23107388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of the OX40/OX40L pathway and induction of PD-L1 synergistically protects mouse islet allografts from rejection.
    Li T; Ma R; Zhu J; Wang F; Huang L; Leng X
    Chin Med J (Engl); 2014; 127(14):2686-92. PubMed ID: 25043090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different costimulatory and growth factor requirements for CD4+ and CD8+ T cell-mediated rejection.
    Vu MD; Amanullah F; Li Y; Demirci G; Sayegh MH; Li XC
    J Immunol; 2004 Jul; 173(1):214-21. PubMed ID: 15210777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel roles of OX40 in the allograft response.
    Demirci G; Li XC
    Curr Opin Organ Transplant; 2008 Feb; 13(1):26-30. PubMed ID: 18660703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential control of allo-antigen-specific regulatory T cells and effector T cells by anti-CD4 and other agents in establishing transplantation tolerance.
    Nagahama K; Fehervari Z; Oida T; Yamaguchi T; Ogawa O; Sakaguchi S
    Int Immunol; 2009 Apr; 21(4):379-91. PubMed ID: 19228878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of OX40 signals enhance survival of xenoislet grafts in spontaneously diabetic NOD mice.
    Honkanen-Scott M; Johnson J; Hering B; Bansal-Pakala P
    Transplant Proc; 2008 Mar; 40(2):483-5. PubMed ID: 18374109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-12p40 is not required for islet allograft rejection.
    Bi EG; Shi W; Zou J; Hao ZH; Li ZH; Cai D; Zhang HQ; Sun B
    Acta Pharmacol Sin; 2006 Aug; 27(8):1065-70. PubMed ID: 16867260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity.
    Kitamura N; Murata S; Ueki T; Mekata E; Reilly RT; Jaffee EM; Tani T
    Int J Cancer; 2009 Aug; 125(3):630-8. PubMed ID: 19455675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.
    Wang L; Han R; Hancock WW
    Eur J Immunol; 2007 Oct; 37(10):2983-90. PubMed ID: 17899549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New insights on OX40 in the control of T cell immunity and immune tolerance in vivo.
    Xiao X; Gong W; Demirci G; Liu W; Spoerl S; Chu X; Bishop DK; Turka LA; Li XC
    J Immunol; 2012 Jan; 188(2):892-901. PubMed ID: 22147766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Islet cell transplantation tolerance.
    Rossini AA; Mordes JP; Greiner DL; Stoff JS
    Transplantation; 2001 Oct; 72(8 Suppl):S43-6. PubMed ID: 11888156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppressing memory T cell activation induces islet allograft tolerance in alloantigen-primed mice.
    Xia J; Chen J; Shao W; Lan T; Wang Y; Xie B; Thorlacius H; Tian F; Huang R; Qi Z
    Transpl Int; 2010 Nov; 23(11):1154-63. PubMed ID: 20536791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OX40 costimulation turns off Foxp3+ Tregs.
    Vu MD; Xiao X; Gao W; Degauque N; Chen M; Kroemer A; Killeen N; Ishii N; Li XC
    Blood; 2007 Oct; 110(7):2501-10. PubMed ID: 17575071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways.
    Nicolls MR; Coulombe M; Beilke J; Gelhaus HC; Gill RG
    J Immunol; 2002 Nov; 169(9):4831-9. PubMed ID: 12391193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade.
    Burrell BE; Lu G; Li XC; Bishop DK
    J Immunol; 2009 Jan; 182(1):379-90. PubMed ID: 19109169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of cyclosporine on transplant tolerance: the role of IL-2.
    Kang HG; Zhang D; Degauque N; Mariat C; Alexopoulos S; Zheng XX
    Am J Transplant; 2007 Aug; 7(8):1907-16. PubMed ID: 17617853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperexpression of Foxp3 and IDO during acute rejection of islet allografts.
    Yang H; Ding R; Sharma VK; Hilaire FS; Lagman M; Li B; Thomas DA; Luo X; Song P; Stauffer C; August P; Suthanthiran M
    Transplantation; 2007 Jun; 83(12):1643-7. PubMed ID: 17589350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralizing interleukin-4 prevents transplant arteriosclerosis mediated by indirect pathway T cells under CD40-CD154 costimulation blockade.
    Spriewald BM; Ensminger SM; Bushell A; Wood KJ
    Transplantation; 2008 Dec; 86(11):1615-21. PubMed ID: 19077898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.